GHO Capital Partners Invests in Genesis Research

11.16.2021

Founded in 2009 and headquartered in Hoboken, New Jersey, Genesis is a pioneer in the emerging field of Real-World Evidence (RWE), servicing market leading innovators across the life sciences industry. Genesis optimizes drug development and evidences the clinical and commercial value of products via expert analysis, synthesis, communication, and utilization of integrated Real-World Data (RWD). Genesis has an established footprint in the U.S. and U.K. with more than 120 employees.